Barclays
LABD icon

Barclays’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Barclays’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-30
Closed -$277K – 7199
2017
Q4 		$277K Hold
30
– – ﹤0.01% 4407
2017
Q3 		$276K Buy
+30
New +$362K ﹤0.01% 4150

Other funds holding LABD

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays's LABD Position: Q1 2018 in Review

Barclays sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2018, closing a stake of 30 shares — an estimated $277K sold.

Barclays first reported a position in LABD in Q3 2017 and held it in 2 quarters. The position peaked at $277K in Q4 2017. 11 funds tracked by Wall St. Rank hold LABD as of Q1 2018.

  • Barclays reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2018 after selling out during the quarter.
  • Barclays sold 30 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2018, an estimated $277K.
  • Barclays first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2017 and held it in 2 quarters.
  • Barclays's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $277K in Q4 2017.
  • 11 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2018.

Based on Barclays's 13F filing for Q1 2018, filed 15 May 2018.